Pricing Log in Create free account

Jaguar Animal Health, Inc. (JAGX) vs NuCana PLC Sponsored ADR (NCNA)

Jaguar Animal Health, Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Jaguar Animal Health, Inc. and NuCana PLC Sponsored ADR are of similar size ($4.2M and $4.1M). NuCana PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. NuCana PLC Sponsored ADR has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (−1,130.2% vs −28,393.6%). Across the 15 metrics below, NuCana PLC Sponsored ADR leads on 10 and Jaguar Animal Health, Inc. on 5.

Valuation

Metric JAGX NCNA Biotechnology median
P/E 0.00 n/m 8.58
P/S 0.00 n/m 10.29
P/B 0.02 0.00 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.14 1.45 0.67
EV/Sales (0.11) n/m 9.89
Earnings yield 82,577.65% (233,383.54%) (31.56%)
Free cash flow yield (6,233.72%) (175,582.84%) (23.42%)

Profitability

Metric JAGX NCNA Biotechnology median
Gross margin 82.31% 0.00% 65.77%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) (68.70%) (54.09%)
Return on assets (127.14%) (45.24%) (47.78%)
Return on invested capital (28,393.64%) (1,130.23%) 0.00%

Growth

Metric JAGX NCNA Biotechnology median
Revenue growth (TTM) 135.52% — 5.83%
EPS growth (last fiscal year) 82.42% 98.96% 29.36%
Revenue growth, 5-year CAGR 4.17% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX NCNA Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 0.69 4.73 4.80
Net debt to EBITDA (0.17) 1.23 0.97

Dividend

Metric JAGX NCNA Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric JAGX NCNA Biotechnology median
Market cap 4.18m 4.14m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack